Expression of cytokeratin 19 and protein p63 in fine needle aspiration biopsy of papillary thyroid carcinoma

Acta Cytologica

Volumn 52, Issue 5, 2008, Pages 541-548

  Bonzanini, Mariella ^a,c   Amadori, Pier Luigi ^b   Sagramoso, Carlo ^a   Dalla Palma, Paolo ^a  

^a SANTA CHIARA HOSPITAL   (Italy)

^b Outpatient Endocrine Service   (Italy)

^c NONE   (Italy)

Author keywords

Aspiration biopsy, fine needle; Cytokeratin 19; Papillary thyroid carcinoma; Protein p63; Thyroid carcinoma

Indexed keywords

CYTOKERATIN 19; PROTEIN P63;

ARTICLE; ASPIRATION BIOPSY; CANCER CYTODIAGNOSIS; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOPLASM; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; NODULAR HYPERPLASIA; PAPILLARY THYROID CARCINOMA; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; STAINING; THYROID CANCER;

EID: 52249108267     PISSN: 00015547     EISSN: 19382650     Source Type: Journal    
DOI: 10.1159/000325595     Document Type: Article

References (49)

1. Hegedus L, Bonnema SJ, Bennedbaek FN: Management of simple nodular goiter: Current status and future perspectives. Endocr Rev 2003:24:102-132
2. Papini E, Guglielmi R, Bianchini A, Crescenzi A, Taccogna S, Nardi F, Panunzi C, Rinaldi R, Toscano V, Pacella CM: Risk of malignancy in nonpalpable thyroid nodules: Predictive value of ultrasound and color-Doppler features. J Clin Endocrinol Metab 2002;87:1941-1946
3. Belfiore A, La Rosa GL: Fine-needle aspiration biopsy of the thyroid. Endocrinol Metab Clin North Am 2001;30:361-400
4. Orell SR, Philips J: The role of fine-needle biopsy in the investigation of thyroid disease and its accuracy. In The Thyroid: Fine-Needle Biopsy and Cytological Diagnosis of Thyroid Lesions. Monographs in Clinical Cytology. Volume 14. The Thyroid. Edited by SR Orell. Basel, S Karger, 1997, pp 8-16
5. Hundahl SA, Fleming ID, Fremgen AM, Menck HR: A National Cancer Data Base report on 53,856 cases of thyroid carcinoma treated in the U.S., 1985-1995. Cancer 1998;15;83: 2638-2648
6. Baloch ZW, Sacks MJ, Yu GH, LiVolsi VA, Gupta PK: Fine needle aspiration of thyroid: An institutional experience. Thyroid 1998;8:565-569
7. Caraway NP, Sneige N, Samaan NA: Diagnostic pitfalls in thyroid fine-needle aspiration: A review of 394 cases. Diagn Cytopathol 1993;9:345-350
8. Miettinen M, Kovatich Aj, Karkkainen P: Keratin subsets in papillary and follicular thyroid lesions: A paraffin section analysis with diagnostic implication. Virchows Arch 1997;431:407-413
9. Fonseca E, Nesland JM, Hoie J, Sobrinho-Simōes M: Patterns of expression of intermediate cytokeratin filaments in the thyroid gland: An immunohistochemical study of simple and stratified epithelial-type cytokeratins. Virchows Arch 1997;430: 239-246
10. Herrmann ME, LiVolsi VA, Pasha TL, Roberts LA, Wojcik EM, Baloch ZW: Immunohistochemical expression of galectin-3 in benign and malignant thyroid lesions. Arch Pathol Med 2002;126:710-713
11. Cheung CC, Ezzat S, Freeman JL, Rosen IB, Asa SL: Immunohistochemical diagnosis of papillary thyroid carcinoma. Mod Pathol 2001;14:338-342
12. Baloch ZW, Abraham S, Roberts S, LiVolsi VA: Differential expression of cytokeratins in follicular variant of papillary carcinoma: An immunohistochemical study and its diagnostic utility. Hum Pathol 1999;30:1166-1171
13. Casey MB, Lohse CM, Lloyd RV: Distinction between papillary thyroid hyperplasia and papillary thyroid carcinoma by immunohistochemical staining for cytokeratin 19, galectin-3 and HBME-1. Endocr Pathol 2003;14:55-60
14. Prasad ML, Pellegata NS, Huang Y, Nagaraja HN, de la Chapelle A, Kloos RT: Galectin-3, fibronectin-1, CITED-1, HBME1 and cytokeratin 19 immunohistochemistry are useful for the differential diagnosis of thyroid tumors. Mod Pathol 2005;18:48-57
15. de Matos PS, Ferreira AP, de Oliveira Facuri F, Assumpção LV, Metze K, Ward LS: Usefulness of HMBE-1, cytokeratin 19 and galectin-3 immunostaining in the diagnosis of thyroid malignancy. Histopathology 2005;47:391-401
16. Rossi ED, Raffaelli M, Mulè A, Miraglia A, Lombardi CP, Vecchio FM, Fadda G: Simultaneous immunohistochemical expression of HBME-1 and galectin-3 differentiates papillary carcinomas from hyperfunctioning lesions of the thyroid. Histopathology 2006;48:795-800
17. Nasser SM, Pitmen MB, Pilch BZ, Faquin W: Fine-needle aspiration biopsy of papillary thyroid carcinoma: Diagnostic utility of cytokeratin 19 immunostaining. Cancer 2000;90:307-311
18. Hirokawa M, Inagaki A, Sonoo H: Expression of cytokeratin 19 in cytologic specimens of thyroid. Diagn Cytopathol 2000;2: 197-198
19. Kamal KK, Luan DT, LiVolsi VA, Baloch ZW: Cytokeratin 19 immunolocalization in cell block preparation of thyroid aspirates: An adjunct to fine-needle aspiration diagnosis of papillary thyroid carcinoma. Arch Pathol Lab Med 2003;127:579-583
20. Unger P, Ewart M, Wang BY, Gan L, Kohtz DS, Burstein DE: Expression of p63 in papillary thyroid carcinoma and in Hashimoto's thyroiditis: A pathobiologic link? Hum Pathol 2003;34:764-769
21. Reis-Filho JS, Preto A, Soares P, Ricardo S, Cameselle-Teijeiro J, Sobrinho-Simōes M: p63 Expression in solid cell nests of the thyroid: Further evidence for a stem cell origin. Mod Pathol 2003;16:43-48
22. Burstein DE, Nagi C, Wang BY, Ungcr P: Immunohistochemical detection of p53 homolog p63 in solid cell nests, papillary thyroid carcinoma, and Hashimoto's thyroiditis: A stem cell hypothesis of papillary carcinoma oncogenesis. Hum Pathol 2004;35:465-473
23. Malaguarnera R, Mandarino A, Mazzon E, Vella V, Gangemi P, Vancheri C, Aloisi A, Vigneri R, Frasca F: The p53-homologue p63 may promote thyroid cancer progression. Endocr Relat Cancer 2005;12:953-971
24. Kim YW, Do IG, Park YK: Expression of the GLUT1 glucose transporter, p63 and p53 in thyroid carcinomas. Pathol Res Pract 2006;202:759-765
25. DeLellis RA, Williams ED: Thyroid and parathyroid tumours: Introduction. In World Health Organization Classification of Tumours: Pathology and Genetics of Tumours of Endocrine Organs. Edited by R DeLellis, RV Lloyd, PU Heitz, C Eng. Lyon, IARC Press, 2004, pp 51-56
26. Shindo M, Wu JC, Park EE, Tanzella F: The importance of central compartment elective lymph node excision in the staging and treatment of papillary thyroid cancer. Arch Otolaryngol Head Neck Surg 2006;132:650-654
27. Doherty GM: Routine central neck lymph node dissection for thyroid carcinoma. Surgery 2006;140:1007-1008
28. Kupferman ME, Patterson DM, Mandel SJ, LiVolsi VA, Weber RS: Safety of modified radical neck dissection for differentiated thyroid carcinoma. Laryngoscope 2004;114:403-406
29. Mehrotra P, Okopokam A, Bouhaidar R, Johnson SJ, Wilson JA, Davies BR, Lennard TW: Galectin-3 does not reliably distinguish benign from malignant thyroid neoplasms. Histopathology 2004;45:493-500
30. Sahoo S, Hoda SA, Rosai J, DeLellis RA: Cytokeratin 19 immunoreactivity in the diagnosis of papillary thyroid carcinoma: A note of caution. Am J Clin Pathol 2001;116:696-702
31. Beesley MF, McLaren KM: Cytokeratin 19 and galectin-3 immunohistochemistry in the differential diagnosis of solitary thyroid nodules. Histopathology 2002;41:236-243
32. Scognamiglio T, Hyjek E, Kao J, Chen YT: Diagnostic usefulness of HBME1, galectin-3, CK 19, and CITED1 and evaluation of their expression in encapsulated lesions with questionable features of papillary carcinoma. Am J Clin Pathol 2006; 126:700-708
33. Yang A, Kagad M, Wang Y, Gillett E, Fleming MD, Dötsch V, Andrews NC, Caput D, McKeon F: p63, A p53 homolog at 3q27-29, encodes multiple products with transactivating, death-inducing, and dominant-negative activities. Mol Cell 1998;2:305-316
34. Koster MI, Roop DR: The role of p63 in development and differentiation of the epidermis. J Dermatol Sci 2004;34:3-9
35. Ince TA, Cviko AP, Quade BJ, Yang A, McKeon FD, Mutter GL, Crum CP: p63 Coordinates anogenital modeling and epithelial cell differentiation in the developing female urogenital tract. Am J Pathol 2002;161:1111-1117
36. Pellegrini G, Dellambra E, Golisano O, Martinelli E, Fantozzi I, Bondanza S, Ponzin D, McKeon F, De Luca M: p63 Identifies keratinocyte stem cells. Proc Natl Acad Sci USA 2001;98: 3156-3161
37. Wang BY, Gil J, Kaufman D, Gan L, Kohtz DS, Burstein DE: p63 In pulmonary epithelium, pulmonary squamous neoplasms and other pulmonary tumors. Hum Pathol 2002;33:921-926
38. Caillou B: Ductal metaplasia in chronic lymphocitic thyroiditis as a manifestation of phylogenentic regression to an exocrine structure. Am J Surg Pathol 2006;30:774-781
39. Ryska A, Ludvikova M, Rydlova M, Cap J, Zalud R: Massive squamous metaplasia of the thyroid gland: Report of three cases. Pathol Res Pract 2006;202:99-106
40. Hunt JL, LiVolsi VA, Barnes EL: p63 Expression in sclerosing mucoepidermoid carcinomas with eosinophilia arising in the thyroid. Mod Pathol 2004;17:526-529
41. Reimann JD, Dorfman DM, Nose V: Carcinoma showing thymus-like differentiation of the thyroid (CASTLE): A comparative study: Evidence of thymic differentiation and solid cell nest origin. Am J Surg Pathol 2006;30:994-1001
42. Lanzafame S, Caltabiano R, Puzzo L, Cappellani A: Thyroid transcription factor 1 (TTF-1) and p63 expression in two primary thyroid papillary carcinomas of the branchial cleft cysts. Virchows Arch 2006;449:129-133
43. Galgano MT, Mills SE, Stelow EB: Hyalinizing trabecular adenoma of the thyroid revisited: A histologic and immunohistochemical study of thyroid lesions with prominent trabecular architecture and sclerosis. Am J Surg Pathol 2006;30:1269-1973
44. Preto A, Reis-Filho JS, Ricardo S, Soares P: p63 Expression in papillary and anaplastic carcinomas of the thyroid gland: Lack of an oncogenetic role in tumorigenesis and progression. Pathol Res Pract 2002;198:449-454
45. Reis-Filho JS, Milanezi F, Amendoeira I, Albergaria A, Schmitt FC: Distribution of p63, a novel myoepithelial marker, in fine-needle aspiration biopsies of the breast: An analysis of 82 samples. Cancer Cytopathol 2003;99:172-179
46. Wang TY, Chen BF, Yang YC, Chen H, Wang Y, Cviko A, Quade BJ, Sun D, Yang A, McKeon FD, Crum CP: Istologic and immunophenotypic classification of cervical carcinomas by expression of the p53 homologue p63: A study of 250 cases. Hum Pathol 2001;32:479-486
47. Park BJ, Lee SJ, Kim JI, Lee SJ, Lee CH, Chang SG, Park JH, Chi SG: Frequent alteration of p63 expression in human primary bladder carcinomas. Cancer Res 2000;60:3370-3374
48. O'Connell JT, Mutter GL, Cviko A, Nucci M, Quade BJ, Kozachewich HP, Neffen E, Sun D, Yang A, McKeon FD, Crum CP: Identification of a basal/reserve cell immunophenotype in benign and neoplastic endometrium: A study with the p53 homologue p63. Gynecol Oncol 2001;80:30-36
49. Carcangiu ML, Zampi G, Rosai J: Poorly differentited ("insular" ) thyroid carcinoma: A reinterpretation of Langhans' "wuchernde sruma." Am J Surg Pathol 1984;8:655-668